Merck Is Benefiting From Keytruda, but Jim Cramer Prefers Eli Lilly

Merck vs. Eli Lilly.
Publish date:

TheStreet's Action Alerts PLUS said Merck (MRK) - Get Report is benefiting from its Keytruda drug but Cramer prefers Eli Lilly (LLY) - Get Report , a holding of his charitable trust.

Watch all of Jim Cramer's latest videos, right here: